chloroquine and imatinib mesylate

chloroquine has been researched along with imatinib mesylate in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (16.67)29.6817
2010's8 (66.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Bellodi, C; Calabretta, B; Dinsdale, D; Donato, N; Dyer, MJ; Galavotti, S; Hamilton, A; Helgason, GV; Holyoake, T; Hunter, A; Lidonnici, MR; Nicotera, P; Ronchetti, M; Salomoni, P; Selmi, T; Soliera, AR; Tirrò, E; Van Etten, RA; Vigneri, P; Yacobi, R; Young, KW1
Baughman, R; Decker, C; Meyer, KC1
Calabretta, B; Salomoni, P1
Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB1
Crowley, LC; McKenna, SL; Nyhan, MJ; O'Donovan, TR1
Blair, K; Boussinesq, M; Eversole, RR; Klion, AD; Mackenzie, CD; Nutman, TB; Nutting, CS; Specht, S; Wanji, S1
Guo, S; Huang, A; Kelly, DF; Liang, Y; Murphy, SF; Shen, H; Sheng, Z; Sobrado, P1
Bekerman, E; Einav, S1
Alshaeri, HK; Natto, ZS1
Rein, T1

Reviews

4 review(s) available for chloroquine and imatinib mesylate

ArticleYear
Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases.
    Clinics in chest medicine, 2010, Volume: 31, Issue:3

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antimetabolites; Autoimmune Diseases; Benzamides; Chloroquine; Cytotoxins; Drug Interactions; Female; Humans; Hydroxychloroquine; Imatinib Mesylate; Immunosuppression Therapy; Immunosuppressive Agents; Male; Piperazines; Pregnancy; Pyrimidines; Tumor Necrosis Factor-alpha

2010
Suppression of autophagy by BCR/ABL.
    Frontiers in bioscience (Scholar edition), 2012, 01-01, Volume: 4, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Benzamides; Chloroquine; Drug Synergism; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction

2012
A contemporary look at COVID-19 medications: available and potentially effective drugs.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Humans; Imatinib Mesylate; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2

2020
Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts.
    Journal of cellular biochemistry, 2022, Volume: 123, Issue:2

    Topics: Antidepressive Agents; Antiviral Agents; Artesunate; Autophagy; Chloroquine; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Endoplasmic Reticulum; Endosomes; Humans; Hydroxychloroquine; Imatinib Mesylate; Infliximab; Intracellular Membranes; Ivermectin; Macrolides; Middle East Respiratory Syndrome Coronavirus; Niclosamide; Pandemics; RNA, Viral; SARS-CoV-2; Virus Replication

2022

Other Studies

8 other study(ies) available for chloroquine and imatinib mesylate

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
    The Journal of clinical investigation, 2009, Volume: 119, Issue:5

    Topics: Animals; Antineoplastic Agents; Autophagy; Benzamides; Calcium; Cell Death; Cell Line, Tumor; Chloroquine; Dasatinib; Endoplasmic Reticulum; Fusion Proteins, bcr-abl; Gene Expression; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Macrolides; Mice; Mice, Inbred C3H; Microtubule-Associated Proteins; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; RNA Interference; Thiazoles; Transcription Factor CHOP; Xenograft Model Antitumor Assays

2009
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
    Experimental parasitology, 2013, Volume: 134, Issue:2

    Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines

2013
Pharmacological agents with inherent anti-autophagic activity improve the cytotoxicity of imatinib.
    Oncology reports, 2013, Volume: 29, Issue:6

    Topics: Antineoplastic Agents; Autophagy; Benzamides; Brefeldin A; Cell Cycle Checkpoints; Cell Shape; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Imatinib Mesylate; K562 Cells; Piperazines; Pyrimidines; Vincristine

2013
Analysis of nematode motion using an improved light-scatter based system.
    PLoS neglected tropical diseases, 2015, Volume: 9, Issue:2

    Topics: Animals; Antiprotozoal Agents; Brugia; Caenorhabditis elegans; Chloroquine; Drug Discovery; Female; Imatinib Mesylate; Larva; Locomotion; Microfilariae

2015
A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications.
    Autophagy, 2015, Volume: 11, Issue:3

    Topics: Animals; Autophagy; Cell Survival; Chloroquine; Dactinomycin; Endosomes; Fluorescent Dyes; Gene Expression Regulation, Leukemic; HEK293 Cells; HeLa Cells; Humans; Imatinib Mesylate; K562 Cells; Leukemia; Lysosomes; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Mice, SCID; Microscopy, Fluorescence; Neoplasm Transplantation; Protein Serine-Threonine Kinases; RNA Interference; Spectrometry, Fluorescence

2015
Infectious disease. Combating emerging viral threats.
    Science (New York, N.Y.), 2015, Apr-17, Volume: 348, Issue:6232

    Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses

2015